Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Global drug screening industry 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Component trends
2.1.4 Sample type trends
2.1.5 Drug type trends
2.1.6 End-use trends
Chapter 3 Drug Screening Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing drug and alcohol consumption
3.2.1.2 Presence of stringent laws to support drug screening
3.2.1.3 Growing availability of products and services for drug-of-abuse testing
3.2.2 Industry pitfalls & challenges
3.2.2.1 Prohibition on workplace drug testing
3.2.2.2 Dearth of trained laboratory professionals
3.3 Growth potential analysis
3.3.1 By component
3.3.2 By sample type
3.3.3 By drug type
3.3.4 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Technology landscape
3.7 Gap analysis
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Company positioning matrix
4.5 Strategy dashboard, 2022
Chapter 5 Drug Screening Market Size and Forecast, By Component (USD Million)
5.1 Key trends, by component
5.2 Products
5.2.1 Analytical instruments
5.2.1.1 Immunoassay Analyzers
5.2.1.2 Chromatographic Analyzers
5.2.1.3 Breath Analyzers
5.2.2 Rapid testing devices
5.2.3 Consumables
5.3 Drug screening services
Chapter 6 Drug Screening Market Size and Forecast, By Sample Type (USD Million)
6.1 Key trends, by sample type
6.2 Urine
6.3 Breath
6.4 Oral fluids
6.5 Hair
6.6 Other sample types
Chapter 7 Drug Screening Market Size and Forecast, By Drug Type (USD Million)
7.1 Key trends, by drug type
7.2 Cannabis/Marijuana
7.3 Opiods
7.4 Alcohol
7.5 Amphetamines
7.6 Other drug types
Chapter 8 Drug Screening Market Size and Forecast, By End-use (USD Million)
8.1 Key trends, by end-use
8.2 Drug testing laboratories
8.3 Workplace
8.4 Hospitals
8.5 Law Enforcement Agencies
8.6 Other end-users
Chapter 9 Drug Screening Market Size and Forecast, By Region (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of MEA
Chapter 10 Company Profiles
10.1 Laboratory Corporation of America
10.2 Quest Diagnostics
10.3 Abbott Laboratories
10.4 OraSure Technologies, Inc.
10.5 Alfa Scientific Designs, Inc.
10.6 Thermo Fisher Scientific Inc.
10.7 Drägerwerk AG & Co. KGaA
10.8 Lifeloc Technologies, Inc.
10.9 Omega Laboratories, Inc.
10.10 Premier Biotech, Inc.
10.11 Psychemedics Corporation
10.12 F. Hoffmann-La Roche Ltd
10.13 Shimadzu Scientific Instruments.
10.14 Siemens Healthineers
